Validating Studies to Assess the Diagnostic Accuracy of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium

Summary

The study has two phases: Phase B and Phase C. The purpose of the Phase B study is to determine the performance (sensitivity and specificity) of a smartphone application (DelApp) to identify delirium in the whole inpatient sample. The study also aims to determine the performance (sensitivity and specificity) of the DelApp to discriminate between delirium (with or without dementia) and dementia (without delirium).

The purpose of the Phase C study is to determine the efficacy of the DelApp software application in detecting delirium in unselected patients in an inpatient sample and to determine the performance of the DelApp to discriminate between delirium and dementia. The study also aims to explore the performance of the DelApp in tracking change in cognitive function.

Conditions

• Delirium
• Dementia

Interventions

OTHER

No intervention given to participants

This is an observational study. Participants will receive no intervention.

Sponsors & Collaborators

• Medical Research Council

  collaborator OTHER_GOV

• NHS Lothian

  collaborator OTHER_GOV

• University of Glasgow

  collaborator OTHER

• NHS Greater Glasgow and Clyde

  collaborator OTHER

• Cambridge Cognition Ltd

  collaborator INDUSTRY

• University of Edinburgh

  lead OTHER

Principal Investigators

• David J Stott · University of Glasgow

• Elizabeth Wilson · Royal Infirmary of Edinburgh

• Timothy Walsh · University of Edinburgh

• Tara Quasim · University of Glasgow

• Jonathan Evans · University of Glasgow

• Christopher Weir · University of Edinburgh

• Alexander Weir · Medical Devices Unit

• Stuart Parks · Medical Devices Unit

• Jennifer Barnett · Cambridge Cognition Ltd

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2015-10-12

Primary Completion

2018-03-22

Completion

2018-03-22

Countries

• United Kingdom

Study Locations